etoposide has been researched along with Jejunal Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avdeef, A; Tam, KY | 1 |
| Arima, F; Kataoka, I; Kobayashi, Y; Matsuno, Y; Nishimoto, J; Shimoda, T; Tamura, R; Tobinai, K; Watanabe, T; Yamamoto, S | 1 |
2 other study(ies) available for etoposide and Jejunal Diseases
| Article | Year |
|---|---|
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Enteropathy-type T-cell lymphoma showing repeated small bowel rupture and refractoriness to chemotherapy: a case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Intestinal Fistula; Intestinal Neoplasms; Intestinal Perforation; Jejunal Diseases; Lymphoma, T-Cell; Male; Prednisone; Rupture, Spontaneous; Vincristine | 2002 |